Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Roivant Sciences

4 Disclosed Funding Rounds $1,893,000,000

4 Participating Investments $156,500,000


Pharmaceutical, Biopharma, Health Care, Biotechnology, Product Research

Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates.

New York, New York, United States, North America (CH)

Organizations in New York in Pharmaceutical,
Organizations in New York in Biopharma,
Organizations in New York in Health Care,
Organizations in New York in Biotechnology,
Organizations in New York in Product Research,
Organizations in New York in Pharmaceutical,
Organizations in New York in Biopharma,
Organizations in New York in Health Care,
Organizations in New York in Biotechnology,
Organizations in New York in Product Research,
Organizations in United States in Pharmaceutical,
Organizations in United States in Biopharma,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in United States in Product Research,
Organizations in North America in Pharmaceutical,
Organizations in North America in Biopharma,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology,
Organizations in North America in Product Research

Investors in New York in Pharmaceutical,
Investors in New York in Biopharma,
Investors in New York in Health Care,
Investors in New York in Biotechnology,
Investors in New York in Product Research,
Investors in New York in Pharmaceutical,
Investors in New York in Biopharma,
Investors in New York in Health Care,
Investors in New York in Biotechnology,
Investors in New York in Product Research,
Investors in United States in Pharmaceutical,
Investors in United States in Biopharma,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in United States in Product Research,
Investors in North America in Pharmaceutical,
Investors in North America in Biopharma,
Investors in North America in Health Care,
Investors in North America in Biotechnology,
Investors in North America in Product Research

East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups), Greater New York Area (0 Investors) (0 Startups)

Founded date 05, 2014

Founders Vivek Ramaswamy

Operating Status Active

Funding Stage Private Equity

Last Funding Type Private Equity

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.

Date Round Raised Lead
November, 13, 2018 Private Equity $200,000,000 Novaquest Capital Management, RTW Investments LLC
August, 09, 2017 Private Equity $1,100,000,000 SoftBank Vision Fund
July, 13, 2016 Private Equity $500,000,000 Viking Global Investors
May, 01, 2014 Private Equity $93,000,000 QVT Financial

Roivant Sciences Participated In the Following Investment Rounds (4)

Organization Name Lead? Round Partners Participating Raise Date
Datavant No Series B ------- $40,000,000 October, 08, 2020
Datavant Yes Undisclosed ------- $40,500,000 May, 01, 2018
Arbutus Biopharma Yes Post-IPO Equity ------- $66,400,000 January, 16, 2018
Arbutus Biopharma Yes Post-IPO Equity ------- $116,000,000 October, 02, 2017

Roivant Sciences Investors (12)

Investor Lead? Round Participating Raise Date Partners
SoftBank Vision Fund No Private Equity $200,000,000 November, 13, 2018 -------
Novaquest Capital Management Yes Private Equity $200,000,000 November, 13, 2018 -------
QVT Financial No Private Equity $200,000,000 November, 13, 2018 -------
Founders Fund No Private Equity $200,000,000 November, 13, 2018 -------
Viking Global Investors No Private Equity $200,000,000 November, 13, 2018 -------
Dexcel Pharma No Private Equity $200,000,000 November, 13, 2018 -------
RTW Investments LLC Yes Private Equity $200,000,000 November, 13, 2018 -------
SoftBank Vision Fund Yes Private Equity $1,100,000,000 August, 09, 2017 -------
Founders Fund No Private Equity $1,100,000,000 August, 09, 2017 -------
Viking Global Investors Yes Private Equity $500,000,000 July, 13, 2016 -------
QVT Financial Yes Private Equity $93,000,000 May, 01, 2014 -------
Dexcel Pharma No Private Equity $93,000,000 May, 01, 2014 -------